[go: up one dir, main page]

WO2005089844A1 - Inhalateur a poudre - Google Patents

Inhalateur a poudre Download PDF

Info

Publication number
WO2005089844A1
WO2005089844A1 PCT/RU2005/000129 RU2005000129W WO2005089844A1 WO 2005089844 A1 WO2005089844 A1 WO 2005089844A1 RU 2005000129 W RU2005000129 W RU 2005000129W WO 2005089844 A1 WO2005089844 A1 WO 2005089844A1
Authority
WO
WIPO (PCT)
Prior art keywords
channel
channels
inhalation
dosing unit
orifice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2005/000129
Other languages
English (en)
Russian (ru)
Inventor
Aleksandr Grigorievich Chuchalin
Evgeny Viktorovich Babarskov
Vladimir Evgenievich Nebolsin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EA200601758A priority Critical patent/EA009895B1/ru
Publication of WO2005089844A1 publication Critical patent/WO2005089844A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Definitions

  • the invention is subject to medical technology, and the name ⁇
  • inhalation includes a convenient drug with a medicinal product
  • ingredients in the form of mixed mixtures of dispersed particles are ingredients in the form of mixed mixtures of dispersed particles
  • particles have sizes of 50-100 microns.
  • Actual component for example,
  • the bulk fraction of the original bulk mixture and includes 3, preferably, particles are interchangeable with
  • the main advantage is the efficiency of the system.
  • Typical 4 voyage maneuver consists of three phases: deep outlet,
  • the mouthpiece is located
  • a wide range of products makes up about 15 percent.
  • the present invention is the creation of such a patent.
  • a generous inhaler including a protective cover 7 rooms, with requirements for the entrance of the air and the exit of the airport,
  • the answer is to send the dose to the dedicated channel
  • each of the channels is divided
  • One of the channels is connected to the distribution channel, and the other channel
  • a simple inhaler is provided in figures 1-4.
  • the inhalation box shown in Figure 2 includes the mouthpiece 3 connected to the dispenser, 9 end 4 for start-up, put 5 to the bottom of the end
  • the dispersed channel and this is the simple inhaler, differs in that
  • Each of the other openings is located in the opposite direction.
  • Part 7 (10) is filled with a simple drug.
  • the return is placed in one of the dispersed channels 2, and this
  • Decommissioned resolution 7 (10) is available prior to delivery.
  • a simple inhaler has a simple and convenient means that
  • the supplement may be any suitable material.
  • the supplement may be any suitable material.
  • the product process offered by the inhaler may be any product process offered by the inhaler.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

La présente invention relève du domaine de l'équipement médical, et se rapporte en particulier à un inhalateur à poudre, qui comprend : un corps coiffé d'un capuchon de protection, qui est doté d'un orifice d'entrée d'air et d'un orifice de sortie d'aérosol, lesdits orifices étant reliés par un conduit d'air contenant des canaux d'accélération reliés à un diffuseur ; un récipient à poudre ; et un dispositif de dosage, qui se présente sous la forme d'une plaque mobile dotée d'un orifice de mesure destiné à fournir une dose de poudre au canal d'accélération. La plaque mobile du dispositif de dosage possède un orifice de mesure supplémentaire, identique au premier, qui est placé à la même distance de l'axe de rotation du dispositif de dosage et forme un angle de 90 ° par rapport au premier orifice, de façon que, lors de la rotation du dispositif de dosage, chacun des orifices de mesure se déplace successivement tantôt sous l'orifice situé à la base du récipient à poudre, tantôt dans l'un des canaux d'accélération. Les canaux d'accélération sont séparés par une cloison qui s'étend à partir de l'une de leurs parois au niveau de leur sortie, est directement adjacente à la plaque mobile du dispositif de dosage, et passe au-dessus de l'orifice de mesure vers les deux canaux, de façon que l'un des canaux seulement soit relié au diffuseur, et que l'autre canal communique avec le premier canal par l'intermédiaire de l'orifice de mesure.
PCT/RU2005/000129 2004-03-23 2005-03-22 Inhalateur a poudre Ceased WO2005089844A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA200601758A EA009895B1 (ru) 2004-03-23 2005-03-22 Порошковый ингалятор

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2004108225 2004-03-23
RU2004108225/14A RU2258539C1 (ru) 2004-03-23 2004-03-23 Порошковый ингалятор

Publications (1)

Publication Number Publication Date
WO2005089844A1 true WO2005089844A1 (fr) 2005-09-29

Family

ID=34993462

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2005/000129 Ceased WO2005089844A1 (fr) 2004-03-23 2005-03-22 Inhalateur a poudre

Country Status (3)

Country Link
EA (1) EA009895B1 (fr)
RU (1) RU2258539C1 (fr)
WO (1) WO2005089844A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2376040C1 (ru) * 2008-05-27 2009-12-20 Александр Григорьевич Чучалин Порошковый ингалятор
EP3291867B1 (fr) 2015-04-15 2021-06-09 Philip Morris Products S.A. Élément d'aromatisation pour un dispositif d'inhalation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4907583A (en) * 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
RU2002467C1 (ru) * 1991-06-25 1993-11-15 Чучалин Александр Григорьевич; Бабарсков Евгений Викторович; Опенев В чеслав Иванович; Зезин Сергей Борисович; Коркина Людмила Георгиевна; Казначеев Владимир Александрович; Лох- мачев Александр Викторович Ингал тор дл введени лекарственных средств в виде порошка
RU2080883C1 (ru) * 1994-11-22 1997-06-10 Александр Григорьевич Чучалин Ингалятор
WO2003000325A1 (fr) * 2001-06-22 2003-01-03 Sofotec Gmbh & Co. Kg Systeme de desintegration de formulation de poudre et procede pour inhalateurs de poudre seche

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE228024T1 (de) * 1994-09-16 2002-12-15 Glaxosmithkline Lab Sas Inhalator

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4907583A (en) * 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
RU2002467C1 (ru) * 1991-06-25 1993-11-15 Чучалин Александр Григорьевич; Бабарсков Евгений Викторович; Опенев В чеслав Иванович; Зезин Сергей Борисович; Коркина Людмила Георгиевна; Казначеев Владимир Александрович; Лох- мачев Александр Викторович Ингал тор дл введени лекарственных средств в виде порошка
RU2080883C1 (ru) * 1994-11-22 1997-06-10 Александр Григорьевич Чучалин Ингалятор
WO2003000325A1 (fr) * 2001-06-22 2003-01-03 Sofotec Gmbh & Co. Kg Systeme de desintegration de formulation de poudre et procede pour inhalateurs de poudre seche

Also Published As

Publication number Publication date
RU2258539C1 (ru) 2005-08-20
EA009895B1 (ru) 2008-04-28
EA200601758A1 (ru) 2007-02-27

Similar Documents

Publication Publication Date Title
Levy et al. Understanding dry powder inhalers: key technical and patient preference attributes
Lavorini et al. Recent advances in capsule-based dry powder inhaler technology
Roche et al. The evolution of pressurized metered-dose inhalers from early to modern devices
Cataldo et al. How to choose the right inhaler using a patient-centric approach?
Dalby et al. Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders
Yousefi et al. CFD simulation of aerosol delivery to a human lung via surface acoustic wave nebulization
Doty et al. Drug delivery from an innovative LAMA/LABA co-suspension delivery technology fixed-dose combination MDI: evidence of consistency, robustness, and reliability
Ferguson et al. Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases
US20040118398A1 (en) Systems and methods for determining a minimum effective dose of an inhaled drug for an individual patient at a given time
Scichilone et al. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
CN101437562A (zh) 具有气动力弹性分散机构的干粉吸入器
Gálffy et al. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD
Weers et al. Dose emission characteristics of placebo PulmoSphere® particles are unaffected by a subject's inhalation maneuver
Chrystyn Closer to an ‘ideal inhaler’with the Easyhaler®: an innovative dry powder inhaler
Anderson et al. Use of spacers for patients treated with pressurized metered dose inhalers: focus on the VENTOLIN™ Mini Spacer
Sidler-Moix et al. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers
Nicolini et al. Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
Abadelah et al. Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler® dry powder inhaler
Lavorini Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease
Chrystyn et al. The dry powder inhaler features of the Easyhaler that benefit the management of patients
Bisgaard Automatic actuation of a dry powder inhaler into a nonelectrostatic spacer
RU2376040C1 (ru) Порошковый ингалятор
Hu et al. Comparison of the performance of inhalation nebulizer solution and suspension delivered with active and passive vibrating-mesh device
Wallin et al. Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study
Cates Spacers and nebulisers for the delivery of beta-agonists in non-life-threatening acute asthma

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 200601758

Country of ref document: EA

122 Ep: pct application non-entry in european phase